Kymera Therapeutics (KYMR) stock hits a new 52-week high driven by positive clinical trial data and strong social media buzz. Analysts are bullish on the biotech sector outlook, further boosting investor confidence.
Kymera Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing novel treatments for immuno-inflammatory diseases.
Kymera Therapeutics, Inc. uses the ticker $KYMR for trading. Listed in the Stocks category within the Healthcare sectors.
Price 24-Hour Time-Series Raw Data
The stock price has reached a 52-week and all-time high, driven by positive clinical trial data, favorable analyst ratings, and significant social media activity, despite a recent dip.
24-Hour: 55.65% 7-Day: 12.95% 30-Day: 29.28%
1-Year High: $94.30 on 2025-12-08
1-Year Low: $21.10 on 2025-04-08
AltRank 24-Hour Time-Series Raw Data
Kymera Therapeutics, Inc. (KYMR) is currently AltRank #663 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [---] [----]
[--] Month: [---] +244
[--] Months: [---] [---]
[--] Year: [---] [----]
1-Year High: [-----] on 2025-02-27
1-Year Low: [--] on 2025-07-06
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-12-08
1-Year Low: [--] on 2026-01-11
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [------]
[--] Week: [-------] +69%
[--] Month: [-------] +42%
[--] Months: [---------] +35%
[--] Year: [---------] +146%
1-Year High: [-------] on 2025-12-08
1-Year Low: [---] on 2025-04-20
Engagements by network (24h): X: [-----] TikTok: [--] Reddit: [--] News: [--] YouTube: [--]
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [---]
[--] Week: [---] +2.50%
[--] Month: [---] +27%
[--] Months: [-----] -26%
[--] Year: [-----] +267%
1-Year High: [-----] on 2025-07-06
1-Year Low: [--] on 2025-04-18
Mentions by network (24h): X: [--] TikTok: [--] Reddit: [--] News: [--] YouTube: [--]
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Kymera Therapeutics, Inc. (KYMR) in the last [--] hours which is down 20% from [--] in the previous [--] hours
Daily Average: [--]
[--] Week: [---] -7.10%
[--] Month: [---] +0.34%
[--] Months: [-----] -33%
[--] Year: [-----] +309%
1-Year High: [---] on 2025-07-06
1-Year Low: [--] on 2025-02-23
The most influential creators that mention Kymera Therapeutics, Inc. in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @HOThomasWPhelps | [--] | [-----] | [--] | [-----] |
| @tradingsssss | [--] | [-----] | [--] | [---] |
| @Andre_AGTC | [--] | [-----] | [--] | [---] |
| @semodough | [--] | [------] | [--] | [--] |
| @barronsonline | [--] | [-------] | [--] | [--] |
| @chaotropy | [--] | [---] | [--] | [--] |
| @financebully | [--] | [-----] | [--] | [--] |
| @BuyTheUgly | [--] | [--] | [--] | [--] |
| @shabeezy84 | [--] | [--] | [--] | [--] |
| @mariostario2019 | [--] | [--] | [--] | [--] |
Sentiment 24-Hour Time-Series Raw Data
Current Value: 94%
Daily Average: 73%
[--] Week: 80% +18%
[--] Month: 88% +22%
[--] Months: 88% +4%
[--] Year: 88% +43%
1-Year High: 100% on 2025-02-23
1-Year Low: 23% on 2025-04-13
Most Supportive Themes:
Most Critical Themes:
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00532%
Daily Average: 0.015%
[--] Week: 0.00555% -0.00335%
[--] Month: 0.011% -0.022%
[--] Months: 0.011% +0.0017%
[--] Year: 0.011% +0.0045%
1-Year High: 0.169% on 2025-07-06
1-Year Low: 0.0029% on 2025-04-08
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.0075%
Daily Average: 0%
1-Year High: 0.009% on 2025-12-08
1-Year Low: 0.00227% on 2025-04-08
Market Cap 24-Hour Time-Series Raw Data
Current Value: $6,587,119,883
Daily Average: $3,695,214,948
[--] Week: $6,591,119,835 +4.30%
[--] Month: $6,587,119,883 +18%
[--] Months: $6,587,119,883 +116%
[--] Year: $6,587,119,883 +176%
1-Year High: $7,543,908,246 on 2025-12-08
1-Year Low: $1,367,074,063 on 2025-04-08
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"$NKTR $CRVS $APGE $KYMR $EVMN why are we even trying to compete with one another 😂 $NKTR $CRVS https://t.co/cJhhh1lPTx $NKTR $CRVS https://t.co/cJhhh1lPTx"
X Link @tradingsssss 2026-02-15T08:45Z [----] followers, [----] engagements
"Summary graphic of atopic dermatitis drugs/targets by benefit/treatment profile: SOC benchmarks: #Dupilumab $SNY $REGN and #Upadacitinib $ABBV Compare to: Injectables in Ph2b trials #APG777 $APGE #Rezpeg $NKTR Oral drugs in Ph2b trials #soquelitinib $CRVS KT-621 $KYMR @JoseRestonVA It's a smart bet I have a slightly different perspective on it: Dupi's [----] LOE will be unique in a way where they will still be a Best in Disease gold standard product. When dupi biosimilars come into the market they will be widely used bc of this gold standard efficacy and @JoseRestonVA It's a smart bet I have a"
X Link @HOThomasWPhelps 2026-02-14T16:24Z [----] followers, [----] engagements
"Different Ph2b AD trial designs orals may take less time than injectables and close gap w/ injectable programs further ahead oral $KYMR KT-621 [--] wks [--] wk open label extension $CRVS #soquelitinib [--] wks 30-day follow-up inj $APGE $NKTR 16wk data [--] wk maintenance https://twitter.com/i/web/status/2022331133032100249 https://twitter.com/i/web/status/2022331133032100249"
X Link @HOThomasWPhelps 2026-02-13T15:24Z [----] followers, [----] engagements
"$CRVS oral ITK inhibitor #soquelitinib AD profile: Works fast as JAKi + EASI-75 benefit months off-treatment Oral therapy in just 4-8 wks offers $ABBV JAKi disease control but better safety + $NKTR #Rezpeg duration Also works in patients that fail #Dupilumab or #Upadacitinib 🚨 Table of Drug Profiles for Different Treatments/Targets in Atopic Dermatitis FDA-approved and In-Development $ABBV $AMGN $APGE $BMY $CRVS $KYMR $LLY $NKTR $PFE $REGN $SNY https://t.co/0x2HOgjhuN 🚨 Table of Drug Profiles for Different Treatments/Targets in Atopic Dermatitis FDA-approved and In-Development $ABBV $AMGN"
X Link @HOThomasWPhelps 2026-02-13T07:10Z [----] followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing